Figure 9
From: Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence
Images showing DCFDA staining under phase contrast microscope after 48 hrs of treatment on osteosarcoma cell lines Saos-2 & MG-63 and adenocarcinoma cell line A549 at 20X magnification. (A) Control of Saos-2 cells, (B) B-GNPs treated Saos-2 cells, (C) B-C-GNPs treated Saos-2 cells, (D) Pure cisplatin treated Saos-2 cells, (E) Control of A549 cells, (F) B-GNPs treated A549 cells, (G) B-C-GNPs treated A549 cells, (H) Pure cisplatin treated A549 cells, (I) Control of MG-63 cells (J) B-GNPs treated MG-63 cells, (K) B-C-GNPs treated MG-63 cells, (L) Pure cisplatin treated MG-63 cells.
